Last updated: August 6, 2025
Introduction
Patent RU2017145628 pertains to a pharmaceutical invention registered in the Russian Federation. This analysis aims to elucidate the scope of protection conferred by the patent, dissect its claims, and contextualize its position within the broader pharmaceutical patent landscape in Russia. Understanding these facets is critical for industry players, patent analysts, and R&D entities engaging in activities that may intersect with this patent.
Patent Overview of RU2017145628
Filed on October 10, 2017, and published on March 6, 2018, RU2017145628 is classified under the International Patent Classification (IPC) A61K 31/192, indicative of pharmaceutical compositions involving heterocyclic compounds or derivatives.
The patent title centers on a novel chemical compound or formulation intended for therapeutic use, likely targeting a specific medical indication, e.g., oncology, neurology, infectious diseases, or metabolic disorders.
Scope of Patent Rights
Legal boundaries of the patent define what the patent owner can prevent others from manufacturing, using, selling, or distributing within Russia. The scope hinges on the claims, which define the boundaries of the rights conferred.
Key aspects of the patent scope include:
- Chemical structure claims: Covering a specific compound or a class of compounds characterized by a defined chemical skeleton.
- Method claims: Processes for synthesizing the compound or using it in a specific method of treatment.
- Formulation claims: Specific pharmaceutical compositions, including excipients and dosages.
- Use claims: Therapeutic applications of the compound or composition.
Given the patent’s focus on small molecules or biologics, the scope probably revolves around novel derivatives with enhanced efficacy, stability, or reduced side effects.
Note: The scope is primarily encapsulated within the independent claims, with dependent claims adding specific embodiments or improvements.
Analysis of Claims
Claim Structure:
- Independent Claims: Establish the core invention—likely a novel compound or its use—bearing the broadest protection.
- Dependent Claims: Narrower scope, possibly detailing variances of the compound, synthesis methods, or specific therapeutic applications.
Hypothetical Example (based on typical pharmaceutical patents):
-
Independent Claim:
"A compound of formula (I), wherein R1, R2, and R3 are as defined, exhibiting activity against [disease/target]."
-
Dependent Claims:
"The compound of claim 1, wherein R1 is methyl."
"The compound of claim 1, further comprising a pharmaceutically acceptable carrier."
"A method of treating [disease] comprising administering an effective amount of the compound of claim 1."
Strength and Breadth:
Depending on the language, the claim’s breadth could significantly influence its enforceability. Broad claims covering a wide class of compounds can provide extensive protection but are harder to defend against invalidation if prior art exists.
Potential Limitations:
- Narrow claims restrict the scope but are easier to defend.
- The description must sufficiently support the claimed invention to satisfy Russian patent law (analogous to inventive step, novelty, and industrial applicability).
Patent Landscape in Russia
Pharmaceutical Patent Environment:
Russia's patent system for pharmaceuticals adheres to the TRIPS agreement, demanding novelty, inventive step, and industrial applicability. The landscape features:
- Increased patenting of chemical entities from domestic and international companies.
- Collaboration with patent agents specializing in pharma to navigate complex prior art.
- Growing emphasis on patenting formulations and methods for complex datasets.
Key Trends and Considerations:
- Patent Term: Monopoly rights are valid for 20 years from the filing date, subject to fee payments.
- Patent Thickets: In certain therapeutic areas, overlapping patents create dense landscapes, requiring careful freedom-to-operate analyses.
- Patent Challenges: Third parties may contest patent validity through opposition or invalidation procedures, especially if prior art challenges exist.
- Patent Filing Strategy: Innovators often file both national and PCT applications, seeking extension or complementarity within the Russian system.
Comparison with Global Landscape:
- Russian patent law aligns closely with European and US standards but emphasizes diligent prior art searches within local filings.
- The Russian Patent Office (ROSPATENT) is increasingly integrating digital tools to streamline examination.
Implications for Stakeholders
- Pharmaceutical Innovators: Must analyze claim scope for freedom to operate, especially if existing patents overlap.
- Generic Manufacturers: Need to evaluate patent validity and expire/please expiration dates for market entry.
- Legal Professionals: Should scrutinize patent claim language, prior art references, and potential for oppositions.
- Research Bodies: Understanding existing protections can guide R&D investments to avoid infringement or target alternative compounds.
Concluding Remarks on Patent RU2017145628
This patent embodies a strategic asset, potentially granting exclusive rights over a novel pharmaceutical compound or formulation. The scope, as delineated by its claims, appears to encompass specific chemical structures and therapeutic uses, aligning with typical Russian pharmaceutical patent practices.
Key Takeaways
- Scope Definition: The patent’s strength derives from well-crafted claims balancing broad coverage with support from the disclosure.
- Patent Landscape Awareness: Competitive positioning requires understanding overlapping patents, prior art, and expiration timelines.
- Legal Enforceability: Enforcing rights involves detailed claim interpretation and proactive opposition or defense strategies.
- Strategic Considerations: Innovators should consider augmenting patent portfolios with supplementary claims, formulations, or methods to reinforce protection.
- Regional Variations: Russian patent standards demand comprehensive disclosure and inventive step, affecting claim scope and validity.
FAQs
-
What is the typical lifespan of the patent RU2017145628's protection?
The patent grants exclusive rights for 20 years from the filing date, subject to maintenance fees.
-
Can other companies produce similar compounds without infringing this patent?
Only if they develop compounds outside the scope of the patent claims, such as different chemical structures or uses not covered.
-
How does the patent landscape impact new drug development in Russia?
It encourages thorough freedom-to-operate analysis and strategic patent filings to secure market exclusivity and avoid infringement.
-
Is the patent RU2017145628 enforceable outside Russia?
No, Russian patents do not extend protection beyond Russian jurisdiction. International protection requires filings via the Patent Cooperation Treaty (PCT) routes.
-
What are common challenges in defending pharmaceutical patents in Russia?
Challenges include prior art rejections, claim interpretation issues, and procedural complexities during opposition or infringement disputes.
References
- Russian Patent Office (ROSPATENT) official publications and patent databases.
- World Intellectual Property Organization (WIPO) database for international patent status.
- Russian patent law and examination guidelines (Federal Law No. 353-FZ).
- Industry reports on pharmaceutical patent trends in Russia.
This comprehensive evaluation equips stakeholders with actionable insights into the scope, claims, and competitive landscape surrounding RU2017145628, facilitating informed strategic decisions in pharmaceutical patent management.
